(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ALLUCENT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

ALLUCENT

ST13

US500000097978222

Classe

35, 41, 42, 45

Pedido

97978222

Registro

7464174

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

53

Atualização mais recente

03/12/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

35, 41, 42, 45

Data de depósito

20/04/2022

Data de registro

30/07/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/07/2024

Última transação

03/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/05/2022

Primeiro uso no comércio

01/05/2022

Código do desenho

3

Tipo de titular

03

Localização do titular

Cary, NC

Examinador

IN,SUNG HYUN

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the word ALLUCENT appearing dark blue with the inside space of the capital letter "A" filled in with an orange triangle in the top half of the "A" that extends between the two outside lines of the "A" and a gold trapezoid in the bottom half of the "A" and the remaining letters appearing in dark blue lowercase.

Titulares e representantes

Titulares

Clinical Services Corporate Operations, Inc.
Clinical Services Corporate Operations, Inc.

Representantes

Laura M. Franco Winston & Strawn LLP

Classificação técnica

Classes Nice

Classe 35Classe 41Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Data managementabstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceuticalbiotechnologymedical devicediagnostics industries; Data managementthe management for others of databases of patient health data

Classe 41

Training and development in the field of conducting clinical trialsconducting tutorialsseminars and workshops in the field of clinical trials; training in the field of computer software supportconducting tutorialsseminars and workshops in the field of software support

Classe 42

Cloud computing featuring software that allows users to collectreviewanalyze and report on clinical research; technical support servicesinstallation and remote administration of softwaretroubleshooting of software problems and hosted software applicationsall for use in connection with medical research and product regulatory approvalenvironmental healthhealth carein relation to the designresearchdevelopmenttesting of new medical products and devices; cloud computing featuring software for providing telehealthtelemedicineremote care and virtual health care services to patients; cloud computing featuring software that allows users to collecttrackretrievevalidatesummarizestatistically analyze and present data used in the areas of medical research and product regulatory approvalenvironmental healthhealth carein relation to the designresearchdevelopmenttesting of new medical products and devices; Cloud computing featuring software to aggregateintegratetransfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflowsanalyticsvisualizationsreporting features to deliverprocessanalyzeelevatedisplay patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databasessystemsplatformsapplicationssoftware that inform clinical researchremote monitoringcare management; technical consulting servicesevaluating the safety of pharmaceuticalmedicalcosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of designplanningimplementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticalsbiotechnologymedical devices and diagnostics for scientific research and for the development of pharmaceuticalbiotechnologymedical device and diagnostic products and methods of use of such devices and products

Classe 45

Development of regulatory compliance strategies in the field of medical researchregulatory compliance consulting in the field of drugbiologiccosmetic and medical device development

Publicações

Histórico de despachos e eventos da marca no USPTO.

53 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

30/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

30/07/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

25/06/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

25/06/2024

DOCK

ASSIGNED TO EXAMINER

25/06/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

21/05/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

21/05/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/05/2024

IUAF

USE AMENDMENT FILED

11/04/2024

DRRR

DIVISIONAL REQUEST RECEIVED

11/04/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

11/04/2024

EISU

TEAS STATEMENT OF USE RECEIVED

11/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/04/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/04/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/04/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/04/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/04/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/04/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

27/03/2024

EX1G

SOU EXTENSION 1 GRANTED

26/03/2024

EXT1

SOU EXTENSION 1 FILED

26/03/2024

EEXT

SOU TEAS EXTENSION RECEIVED

26/03/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

31/10/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/09/2023

PUBO

PUBLISHED FOR OPPOSITION

05/09/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

16/08/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/07/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

29/07/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

29/07/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

29/07/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

29/07/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

13/07/2023

PBSR

WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST

13/07/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/06/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

21/06/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

16/05/2023

GNFR

FINAL REFUSAL E-MAILED

16/05/2023

CNFR

FINAL REFUSAL WRITTEN

16/05/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/04/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/04/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/01/2023

GNRT

NON-FINAL ACTION E-MAILED

06/01/2023

CNRT

NON-FINAL ACTION WRITTEN

06/01/2023

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

04/01/2023

DOCK

ASSIGNED TO EXAMINER

28/12/2022

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

21/11/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

27/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/04/2022

NWAP

NEW APPLICATION ENTERED

23/04/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ALLUCENT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.